Related Experiment Video
Updated: Mar 25, 2026
Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor
Published on: June 14, 2011
Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation
Yong-Ung Lee1, Nathan Mahler1, Cameron A Best1
1Tissue Engineering Program, The Research Institute at Nationwide Children's Hospital, 700 Children's Drive - WB4151, Columbus, OH 43205-2664, USA.
Aim:
We investigated the effect of cell seeding dose and incubation time on tissue-engineered vascular graft (TEVG) patency.
Materials & Methods:
Various doses of bone marrow-derived mononuclear cells (BM-MNCs) were seeded onto TEVGs, incubated for 0 or 12 h, and implanted in C57BL/6 mice. Different doses of human BM-MNCs were seeded onto TEVGs and measured for cell attachment.
Results:
The incubation time showed no significant effect on TEVG patency. However, TEVG patency was significantly increased in a dose-dependent manner. In the human graft, more bone marrow used for seeding resulted in increased cell attachment in a dose-dependent manner.
Conclusion:
Increasing the BM-MNC dose and reducing incubation time is a viable strategy for improving the performance and utility of the graft.
